Professor Bloom held that during the 1980s most haemophilia specialists recognised the risk of hepatitis in haemophiliacs after treatment with concentrates, however the general belief was that bleeding was still the primary cause of death amongst patients. Read more about Professor Bloom held that during the 1980s most haemophilia specialists recognised the risk of hepatitis in haemophiliacs after treatment with concentrates, however the general belief was that bleeding was still the primary cause of death amongst patients.
Professor Bloom held that during the 1970s that although most patients were infected with NANB Hepatitis, patients did not suffer from clinical liver disease. Read more about Professor Bloom held that during the 1970s that although most patients were infected with NANB Hepatitis, patients did not suffer from clinical liver disease.
Dr Saad Al-Ismail was one of many clinicians that gave evidence to the inquiry who argued that patients were informed of the risks of hepatitis. Read more about Dr Saad Al-Ismail was one of many clinicians that gave evidence to the inquiry who argued that patients were informed of the risks of hepatitis.
Dr Saad Al-Ismail who worked with Professor Bloom in Swansea recalled Professor Bloom stating that NANBH was probably not going to be an issue for the vast majority of patients. Read more about Dr Saad Al-Ismail who worked with Professor Bloom in Swansea recalled Professor Bloom stating that NANBH was probably not going to be an issue for the vast majority of patients.
Professor Ludlam stated that during the 1980s that there was a wide view at the time regarding the seriousness of NANB Hepatitis. The lack of evidence about its progressiveness that resulted in the belief that it's possible it might not be progressive however it became clear that there was a wide range of ways in which it rates at which it did progress between different people. Read more about Professor Ludlam stated that during the 1980s that there was a wide view at the time regarding the seriousness of NANB Hepatitis. The lack of evidence about its progressiveness that resulted in the belief that it's possible it might not be progressive however it became clear that there was a wide range of ways in which it rates at which it did progress between different people.
Professor Ludlam, under counsels questions, amended his earlier submission that in the late 1980s, NANB Hepatitis was believed to be a mild non-progressive condition following the first liver biopsy undertaken in 1985. He corrected this view to say that he was aware of the liver biopsy undertaken in Sheffield in 1978, and thus there was a likelihood of prior knowledge of the condition of NANB Hepatitis earlier than the late 1980s. Read more about Professor Ludlam, under counsels questions, amended his earlier submission that in the late 1980s, NANB Hepatitis was believed to be a mild non-progressive condition following the first liver biopsy undertaken in 1985. He corrected this view to say that he was aware of the liver biopsy undertaken in Sheffield in 1978, and thus there was a likelihood of prior knowledge of the condition of NANB Hepatitis earlier than the late 1980s.
Professor Ludlam described how batch dedication was introduced towards the end of 1984 and it unclear why this was not produced earlier. Read more about Professor Ludlam described how batch dedication was introduced towards the end of 1984 and it unclear why this was not produced earlier.
Professor Ludlam described in his oral evidence how in many cases children with Haemophilia A would begin with cryoprecipitate before moving to home treatment. Read more about Professor Ludlam described in his oral evidence how in many cases children with Haemophilia A would begin with cryoprecipitate before moving to home treatment.
Towards the end of 1982, concerns arose as to the increased demand and limited supply of commercial treatment following the increase in home treatment. It was therefore necessary for more commercial product to be imported and Dr Ludlam agreed to keep up with the demand. Read more about Towards the end of 1982, concerns arose as to the increased demand and limited supply of commercial treatment following the increase in home treatment. It was therefore necessary for more commercial product to be imported and Dr Ludlam agreed to keep up with the demand.
The effect of Professor Ludlam's introduction to factor concentrates was that the local blood transfusion service redirected donor blood plasma from cryoprecipitate production to concentrate manufacture. Read more about The effect of Professor Ludlam's introduction to factor concentrates was that the local blood transfusion service redirected donor blood plasma from cryoprecipitate production to concentrate manufacture.